Roan Holdings Group Announces Agreement to Set Up Joint Venture to Expand in Consumer Health Services Market
BEIJING and HANGZHOU, China, Oct. 14, 2021 /PRNewswire/ -- Roan Holdings Group Co., Ltd. ("Roan" or the "Company") (OTC Pink: RAHGF and RONWF), a provider of diversified solutions in financial, insurance and healthcare related products and management services, today announced that the Company's subsidiary, Yifu Health Industry (Ningbo) Co., Ltd. ("Yifu") has signed a cooperation agreement (the "Agreement") with...
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms
The company's PIONEER™, EDEN™, and RAVEN™ platforms mimic the human immune system to simplify the drug development process for a range of diseases LONDON, Oct. 14, 2021 /PRNewswire/ -- Based on its recent analysis of the European AI-enabled drug discovery market, Frost & Sullivan recognizes Evaxion Biotech A/S (Evaxion) with the 2021 Europe Enabling Technology Leadership Award for aiding...
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused...
A China-developed COVID-19 vaccine is conducting clinical trial in Philippines
CHENGDU, China, Oct. 14, 2021 /PRNewswire/ -- Philippines is currently conducting, along with other countries including Indonesia, Kenya, and Mexico, a Phase III clinical trial of Recombinant COVID-19 Vaccine (Sf9 cells) produced by WestVac Biopharma Co., LTD and National Key Laboratory of Biotherapy, West China Hospital of Sichuan University from China. So far, more than 10,000 subjects worldwide have...
Restart-A-Heart Day – Targets Aussie Women
MELBOURNE, Australia, Oct. 14, 2021 /PRNewswire/ -- Recent studies reveal women are 27% less likely to receive CPR in a public setting compared to men. This has resulted in women dying unnecessarily while waiting for an ambulance as bystanders watch on. "This unfair disparity is likely caused...
1 in 6 People Worldwide Struggles to Read Due to Irlen Syndrome
JOSEPH, Ore., Oct. 14, 2021 /PRNewswire/ -- Millions of children and adults around the world cope with Irlen Syndrome - the inability of the brain to process certain light waves, or colors. The condition falls on a spectrum from mild to severe with symptoms that can include difficulty with reading and math, sensitivity to light, headaches, stomachaches, dizziness, inability...
FII 5th Anniversary Brings Together 250+ Leaders to Invest in Humanity
· The 5th Anniversary of the Future Investment Initiative will be held October 26 – 28 in the Saudi capital Riyadh under the theme "Invest in Humanity". · More than 250 speakers will attend, including heads of state, global executives, policymakers, investors, and innovators. RIYADH, Saudi Arabia, Oct. 14, 2021 /PRNewswire/ -- The 5th Anniversary of the Future Investment Initiative (FII), set to take place October 26 – 28 in...
Over 50% of Hospitals will Accelerate Digital Investments to Meet the Quadruple Aim
Organizations' robust move to improve customer experience and operational efficiencies drives the digital health solutions market, finds Frost & Sullivan SAN ANTONIO, Oct. 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the healthcare sector's increasing focus on meeting the Quadruple Aim—enhancing patient experience, reducing costs, improving health outcomes, and improving clinician experience—has encouraged healthcare organizations to invest...
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year
New NCCN Guidelines for Patients: Basal Cell Skin Cancer empowers patients and caregivers with knowledge about this widespread, preventable, and easily-cured cancer plus the rare subset that requires more aggressive treatment. PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines...
One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center...
The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalizations. Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after...
